Detailed Program
- Current Page
- Program > Detailed Program
English Session
Korean SessionMorning Session 1 
Hypertension: What's New in Diagnosis and Treatment?
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room A | ||||
| 08:00-09:00 |
KOR
Morning Session 1 Hypertension: What's New in Diagnosis and Treatment? |
Seonghoon Choi (Hallym Univ., Korea) | ||
| 08:00-08:30 | Approaches for the Medical Management of Resistant Hypertension | Chan Joo Lee (Yonsei Univ., Korea) | ||
| 08:30-09:00 | Why You Need to Include Night-BP as Part of Routine Hypertension Diagnosis Protocol | Jung Woo Son (Yonsei Wonju Univ., Korea) | ||
[Joint Session with KTCVS] Recent Updates in Surgical Treatments for Heart Failure
|
Room A Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | KOR [Joint Session with KTCVS] Recent Updates in Surgical Treatments for Heart Failure |
Mi-Seung Shin (Gachon Univ., Korea)
, Young-Nam Youn (Yonsei Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
| 심부전환자에서 수술적 치료가 필요한 상황과 위험-이득에 대해 심부전 전문가의 강의를 듣고, Surgeon들에게 각 수술에 대해 수술 영상과 함께 경험한다. | ||||
| 심부전 환자에서 적용되는 수술적 치료 방법이 많이 발전하였고, 수술 시간도 짧아졌지만, 막연한 두려움이 있다. 대한심장혈관흉부외과 학회에서 초청한 외과 교수님들의 실제 수술 경험과 발전을 들을 수 있는 세션이다. | ||||
| 09:00-09:15 | Evaluating Risks and Benefits of Surgical Treatments in HF Patients |
|
Hyung Yoon Kim (Incheon Sejong Hospital, Korea) | |
| 09:15-09:30 | Surgical Treatment for Functional Tricuspid Regurgitation: What's New? [with VIDEO] |
|
Jae Suk Yoo (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 09:30-09:45 | AF Surgery and LAA Clipping: To Whom, How To? [with VIDEO] |
|
Hyunggon Je (Seoul National Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 09:45-10:00 | Surgical Challenges during and after VAD [with VIDEO] |
|
Yu Rim Shin (Yonsei Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 10:00-10:20 | Discussion |
Jihoon Kim (Hallym Univ., Thoracic and Cardiovascular Surgery, Korea) , Dong Ryeol Ryu (Kangwon National Univ., Korea) , Dae-Hwan Bae (Bucheon Sejong Hospital, Korea) , Jiwon Seo (Yonsei Univ., Korea) |
||
[Joint Session with KSE] Hemodynamics Assessment and Imaging for HF
|
Room A Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | KOR [Joint Session with KSE] Hemodynamics Assessment and Imaging for HF |
Dae-Gyun Park (Hallym Univ., Korea)
, Haeok Jung (The Catholic Univ., Korea) |
||
| POCUS부터 비침습적, 침습적 혈역학적 평가까지 심초음파검사를 통해서 얻어진 정보를 해석하고 Hemodynamics는 이해하여 심부전환자의 진단과 치료에 실제적인 도움이 되었으면 한다. | ||||
| 심부전환자의 진단과 위험도 평가에 빠질 수 없는 심장초음파를 이용한 진단과 혈역학적 평가에 대해서 다양한 임상상황에서 이해하고 적용해 본다. | ||||
| 10:40-10:55 | Point of Care Ultrasound for HF Patients in Emergency Department |
|
Kang-Un Choi (Yeungnam Univ., Korea) | |
| 10:55-11:10 | Bedside Echocardiography in Critically Ill Patients: What Should We Evaluate? |
|
Jung Hyun Choi (Pusan National Univ., Korea) | |
| 11:10-11:25 | Clinical Application of Left Atrial Strain and Invasive LA Hemodynamics |
|
Jihoon Kim (Sungkyunkwan Univ., Korea) | |
| 11:25-11:40 | Assessment of Right Ventricle and Pulmonary Hemodynamics: Make It Simple |
|
Seo-Yeon Gwak (Korea Univ., Korea) | |
| 11:40-12:00 | Discussion |
Jino Park (Inje Univ., Korea) , Jin Wi (Gachon Univ., Korea) , Nuri Lee (Chonnam National Univ., Korea) , Kyeong-Hyeon Chun (Yonsei Univ., Korea) |
||
Luncheon Session 4 
Advancing Quality in Heart Failure: Entresto at the Core
| Room A | ||||
| 12:00-13:00 |
ENG
Luncheon Session 4 Advancing Quality in Heart Failure: Entresto at the Core |
Byung-Hee Oh (Incheon Sejong Hospital, Korea) | ||
| 12:00-13:00 | The Myth of the “Stable” Heart Failure Patient: ARNI and the Risks of Omission | Stephen Greene (Duke Univ., USA) | ||
[Joint Session with KCSWG] Cardiogenic Shock - Expanding the Horizons of MCS
|
Room A Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | KOR [Joint Session with KCSWG] Cardiogenic Shock - Expanding the Horizons of MCS |
Min-Seok Kim (Ulsan Univ., Korea)
, Jeong Hoon Yang (Sungkyunkwan Univ., Korea) |
||
| 심인성쇼크 치료에 쓸 수 있는 다양한 기계순환보조(MCS) 장비들의 특성과 활용 방안에 대해 파악한다. | ||||
| 대한심인성쇼크 연구회와의 조인트 세션으로 심인성쇼크에서 MCS의 적용 현황과 다양한 MCS 장치들의 사용 전망에 대해 내과와 외과가 만나 같이 토론한다. | ||||
| 13:00-13:15 | Current Status and Outcomes of MCS in Cardiogenic Shock in Korea: Insights from Registry Data |
|
Ki Hong Choi (Sungkyunkwan Univ., Korea) | |
| 13:15-13:30 | Left Heart Venting in VA ECMO: Armamentarium of Techniques and Approaches |
|
Jae Seung Jung (Korea Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 13:30-13:45 | Impella Heart Pumps: Current Status, Clinical Impact, and Domestic Introduction |
|
Hyun-Jai Cho (Seoul National Univ., Korea) | |
| 13:45-14:00 | CentriMag: Overview, Clinical Applications, and Initial Experience in Korea |
|
Seunghwan Song (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea) | |
| 14:00-14:20 | Discussion |
Dae-Hwan Bae (Bucheon Sejong Hospital, Korea) , Seung Hun Lee (Chonnam National Univ., Korea) , Hee Jeong Lee (Keimyung Univ., Korea) , Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
The Role of AI and Beta-Blockers in Heart Failure Treatment
| Room A | ||||
| 14:20-15:30 |
KOR
The Role of AI and Beta-Blockers in Heart Failure Treatment |
Dong-Ju Choi (Seoul National Univ., Korea)
, Sang-Ho Jo (Hallym Univ., Korea) |
||
| 14:20-14:50 | Bisoprolol in HF: Still Essential Against Overdrive |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 14:50-15:20 | Recent Advances and Clinical Applications of AI in Electrocardiography |
|
Junmyung Kwon (Medical AI, Korea) | |
| 15:20-15:30 | Discussion | |||
[Joint Session with KPHS] Right Heart Failure and Pulmonary HTN
|
Room A Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | KOR [Joint Session with KPHS] Right Heart Failure and Pulmonary HTN |
Wook-Jin Chung (Gachon Univ., Korea)
, Gi Beom Kim (Seoul National Univ., Pediatrics, Korea) |
||
| 우심부전 및 폐고혈압에 대한 진단과 최신 치료법을 안다. | ||||
| 우심부전과 폐고혈압의 병태생리 및 진단방법, 최신 치료 약제와 치료법에 대한 정보 공유하고 토론하는 세션으로 우심부전과 폐고혈압이 아직도 어렵게 느껴진다면, 이 세션을 들어보자. | ||||
| 15:40-15:55 | Understanding the Right Ventricle: Why It Fails in Pulmonary Hypertension |
|
Wook-Jin Chung (Gachon Univ., Korea) | |
| 15:55-16:10 | Advancing Diagnostics: Imaging and Hemodynamics in Right Heart Failure |
|
Jae-Hyeong Park (Chungnam National Univ., Korea) | |
| 16:10-16:25 | Pulmonary Vasodilators and Beyond: Latest Therapeutic Strategies for Pulmonary Hypertension |
|
Sanghyun Lee (Pusan National Univ., Korea) | |
| 16:25-16:40 | Bridging the Gap: Mechanical Support and Transplantation in End-Stage Right Heart Failure |
|
Ah-Ram Kim (Ulsan Univ., Korea) | |
| 16:40-17:00 | Discussion |
Bong-Joon Kim (Kosin Univ., Korea) , Jae Seung Lee (Ulsan Univ., Pulmonology, Korea) , Ji Hyun Cha (Sungkyunkwan Univ., Korea) , Ran Heo (Hanyang Univ., Korea) |
||
Morning Session 2 
| Room B | ||||
| 08:00-09:00 |
KOR
Morning Session 2
|
Seok Min Kang (Yonsei Univ., Korea) | ||
| 08:00-08:30 | Jardiance, The First Successful Result for Chronic Heart Failure with Preserved Ejection Fraction | Mi-Na Kim (Korea Univ., Korea) | ||
| 08:30-09:00 | Should Jardiance be Used as 1st Essential Medication for Chronic Heart Failure, Regardless of LVEF | Kyeong-Hyeon Chun (Yonsei Univ., Korea) | ||
Hypertrophic Cardiomyopathy in 2025
|
Room B Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | ENG Hypertrophic Cardiomyopathy in 2025 |
Dong Heon Yang (Kyungpook National Univ., Korea)
, Eui-Young Choi (Yonsei Univ., Korea) |
||
| This session aims to provide an up-to-date understanding of the evolving landscape of hypertrophic cardiomyopathy (HCM) management by addressing advances in genetics and precision medicine, the role of cardiac imaging in the era of myosin inhibitors, and the development of novel pharmacologic therapies. | ||||
| As knowledge and technology in HCM rapidly advance, 2025 represents a turning point in the way this disease is diagnosed, risk-stratified, and treated. | ||||
| 09:00-09:20 | Genetics and Precision Medicine in Diagnosing and Risk Stratification in HCM |
|
Seitaro Nomura (The Univ. of Tokyo, Japan) | |
| 09:20-09:40 | Role of Imaging in HCM in the Era of Cardiac Myosin Inhibitor |
|
Chi Young Shim (Yonsei Univ., Korea) | |
| 09:40-10:00 | From Beta-blockers to Myosin Inhibitors: Evolving Pharmacologic Therapies for HCM |
|
Carolyn Ho (Brigham and Women's Hospital, USA) | |
| 10:00-10:20 | Discussion |
Jang-Won Son (Yeungnam Univ., Korea) , Hyun-Jung Lee (Yonsei Univ., Korea) , Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) , Jung Hyun Choi (Pusan National Univ., Korea) |
||
[Joint Session with HFA-ESC] How to Enhance a Personalized Strategy for HF Management
|
Room B Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | ENG [Joint Session with HFA-ESC] How to Enhance a Personalized Strategy for HF Management |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Gianluigi Savarese (Karolinska Institutet, Sweden) |
||
| This session aims to explore practical and evidence-based strategies for implementing personalized heart failure (HF) care, focusing on decongestion, biomarker-guided therapy, and optimization during the transitional period following acute decompensation. | ||||
| As heart failure management evolves toward individualized care, a personalized approach is essential to improve patient outcomes across diverse clinical scenarios. This joint session with the European Society of Cardiology – Heart Failure Association (HFA-ESC) highlights critical components of tailored HF management. | ||||
| 10:40-11:00 | Dietary Sodium, Fluid Intake and Decongestion in Heart Failure |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 11:00-11:20 | Biomarkers: Optimizing Treatment Guidance in Heart Failure |
|
Byung Su Yoo (Yonsei Wonju Univ., Korea) | |
| 11:20-11:40 | Optimization of HF Care during Transitional Period in Acute HF Patients |
|
Marco Metra (University of Brescia, Italy) | |
| 11:40-12:00 | Discussion |
Sung-Hee Shin (Inha Univ., Korea) , Chi Young Shim (Yonsei Univ., Korea) , In-Chang Hwang (Seoul National Univ., Korea) , Novi Yanti Sari (Siloam Hospitals Lippo Village, Jakarta, Indonesia) |
||
Luncheon Session 5 
Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT
| Room B | ||||
| 12:00-13:00 |
ENG
Luncheon Session 5 Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT |
Kyu Hyung Ryu (Techo Santepheap National Hospital, Cambodia)
, Seongwoo Han (Hallym Univ., Korea) |
||
| 12:00-12:45 | Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT | Barry Greenberg (Univ. of California San Diego, USA) | ||
| 12:45-13:00 | Discussion | |||
Hematologic Problems Related to Heart Failure
|
Room B Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | ENG Hematologic Problems Related to Heart Failure |
Eunseok Jeon (Sungkyunkwan Univ., Korea)
, Chang-Ki Min (The Catholic Univ., Korea) |
||
| To understand the pathophysiology and clinical implications of anemia, CHIP, cardiac amyloidosis, and hematologic malignancies in heart failure, and how these conditions impact diagnostic and therapeutic strategies. | ||||
| This session will explore key hematologic conditions frequently encountered in heart failure, including anemia, clonal hematopoiesis, and amyloidosis. It will also highlight the cardiovascular complications of hematologic malignancies and treatment-related cardiotoxicity. Through case-based and mechanistic insights, the session aims to provide a multidisciplinary perspective on integrating hematologic factors into heart failure management. | ||||
| 13:00-13:15 | Iron Deficiency, Anemia, and Transfusion in Heart Failure |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 13:15-13:30 | CHIP (Clonal Hematopoiesis of Indeterminate Potential) in CVD: A New Frontier in Cardio-Hematology |
|
Jun-Bean Park (Seoul National Univ., Korea) | |
| 13:30-13:45 | AL Amyloidosis: What Cardiologists Need to Know |
|
Jeong-Eun Yi (The Catholic Univ., Korea) | |
| 13:45-14:00 | Atrial Fibrillation in Cardiac Amyloidosis |
|
Yasuhiro Izumiya (Kumamoto Univ., Japan) | |
| 14:00-14:20 | Discussion |
Kyu-Yong Ko (Inje Univ., Korea) , Hyung Yoon Kim (Incheon Sejong Hospital, Korea) , Kyeong-Hyeon Chun (Yonsei Univ., Korea) |
||
When to Look for Amyloidosis? Early Clinical Clues to Raise Diagnostic Suspicion
| Room B | ||||
| 14:20-15:30 |
ENG
When to Look for Amyloidosis? Early Clinical Clues to Raise Diagnostic Suspicion |
Jin-Oh Choi (Sungkyunkwan Univ., Korea)
, Marcus Urey (Univ. of California San Diego, USA) |
||
| 14:20-14:50 | Navigating Early Diagnosis of ATTR Amyloidosis in Clinical Practice |
|
Marcus Urey (Univ. of California San Diego, USA) | |
| 14:50-15:05 | Sharing Real World Experiences of Diagnosed Amyloidosis I |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 15:05-15:20 | Sharing Real World Experiences of Diagnosed Amyloidosis II |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:20-15:30 | Discussion | Yoonjee Park (Bucheon Sejong Hospital, Korea) | ||
[Joint Session with KHRS] Arrhythmia and Device Therapy in HF
|
Room B Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | ENG [Joint Session with KHRS] Arrhythmia and Device Therapy in HF |
Dae-Gyun Park (Hallym Univ., Korea)
, Seil Oh (Seoul National Univ., Korea) |
||
| To understand the indications, benefits, and risks of catheter ablation and cardiac resynchronization therapy in heart failure patients with arrhythmia. | ||||
| This session will review catheter ablation strategies in heart failure with atrial fibrillation, including patient selection and real-world outcomes. It will also discuss the detection and management of asymptomatic arrhythmias, and present practical guidance on optimizing CRT. By integrating electrophysiologic interventions into heart failure care, the session aims to improve rhythm control and patient prognosis. | ||||
| 15:40-15:55 | HF with Atrial Fibrillation: Patients for Whom Catheter Ablation May be Beneficial |
|
Jun Kim (Ulsan Univ., Korea) | |
| 15:55-16:10 | HF with Atrial Fibrillation: Common and Rare Concerns of Catheter Ablation |
|
Jiwon Seo (Yonsei Univ., Korea) | |
| 16:10-16:25 | How to Diagnose and Manage Asymptomatic Arrhythmia in HF Patients? |
|
Eue-Keun Choi (Seoul National Univ., Korea) | |
| 16:25-16:40 | A Practical Approach to Optimize Cardiac Resynchronization Therapy |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 16:40-17:00 | Discussion |
Tae-Hoon Kim (Yonsei Univ., Korea) , Yoonjee Park (Bucheon Sejong Hospital, Korea) , Youngjin Cho (Seoul National Univ., Korea) |
||
KSHF Lifetime Achievement Award
| Room B | ||||
| 17:10-18:10 | KOR KSHF Lifetime Achievement Award |
Dae-Gyun Park (Hallym Univ., Korea)
, Byung Su Yoo (Yonsei Wonju Univ., Korea) |
||
| 17:10-17:15 | Introduction of Lifetime Achievement Award | Wook-Jin Chung (Gachon Univ., Korea) | ||
| 17:15-17:35 | History of Heart Failure Treatment |
|
Myung-A Kim (Seoul National Univ., Korea) | |
| 17:35-17:40 | Introduction of Lifetime Achievement Award | Wook-Jin Chung (Gachon Univ., Korea) | ||
| 17:40-18:00 | The Heart Failure Odyssey: From Bench to Cyber |
|
Dong-Ju Choi (Seoul National Univ., Korea) | |
| 18:00-18:10 | Congratulatory Remarks | Byung Su Yoo (Yonsei Wonju Univ., Korea) | ||
Oral Presentation & HF Research Award
| Room C | ||||
| 09:00-10:20 | ENG Oral Presentation & HF Research Award |
Jin-Ok Jeong (Chungnam National Univ., Korea)
, Kye Hun Kim (Chonnam National Univ., Korea) |
||
| Judges: Min Gyu Kong (Soon Chun Hyang Univ., Korea), Bong-Joon Kim (Kosin Univ., Korea), Jong-Ho Nam (Yeungnam Univ., Korea), Ju-Hee Lee (Chungbuk National Univ., Korea) | ||||
| 09:00-09:10 | Deep Learning-based Modeling of Gender-Affirming Hormone Therapy and Circulating miRNA Signatures to Predict Heart Failure Risk in Transgender Individuals | Rifaldy Fajar (IMCDS-BRF, Indonesia) | ||
| 09:10-09:20 | Clinical Implications of Significant Tricuspid Regurgitation in LVAD Recipients: Prognostic Relevance and Postoperative Trajectory | Heayoung Shin (Sungkyunkwan Univ., Korea) | ||
| 09:20-09:30 | Immunopathologic Features of Biopsy-Confirmed Myocarditis after COVID-19 mRNA Vaccination | Eui-Soon Kim (The Catholic Univ., Korea) | ||
| 09:30-09:40 | Comparative Prognostic Value of Frailty Assessment Tools in Older Patients with Heart Failure: A Post-hoc Analysis of FRAGILE-HF | Yoshiaki Ikeda (Juntendo Univ., Japan) | ||
| 09:40-09:50 | High Versus Low Positive End-Expiratory Pressure in Mechanically Ventilated Patients with Acute Heart Failure | Min-Seok Kim (Ulsan Univ., Korea) | ||
| 09:50-10:00 | Relationship between Left Ventricular Reverse Remodeling and Guideline-Directed Medical Therapy Intensity Score in De Novo Heart Failure with Reduced Ejection Fraction Patients: Insight from TRANS-HF trial | Taeil Yang (Gachon Univ., Korea) | ||
| 10:00-10:10 | Real-world Eligibility of Finerenone in Patients with Heart Failure: Insights from the Korean Heart Failure III (KorHF III) Registry | Moojun Kim (Yonsei Univ., Korea) | ||
| 10:10-10:20 | Impact of Cardiac Contractility Modulation on Reverse Remodeling and Clinical Outcomes in Heart Failure: A Systematic Review and Meta-analysis | David Yobel (Ngoerah Hospital, Indonesia) | ||
Young Investigator Award Session
| Room C | ||||
| 10:40-12:01 | ENG Young Investigator Award Session |
Mi-Seung Shin (Gachon Univ., Korea)
, Seonghoon Choi (Hallym Univ., Korea) |
||
| Judges: Jang-Won Son (Yeungnam Univ., Korea), Minjae Yoon (Seoul National Univ., Korea), Mi-Hyang Jung (The Catholic Univ., Korea), Uram Jin (Ajou Univ., Korea) | ||||
| 10:40-10:49 | Modification of Stress Echocardiography Criteria in HFA-PEFF Algorithm: Based on the Hemodynamic Study | Ji Hyun Cha (Sungkyunkwan Univ., Korea) | ||
| 10:49-10:58 | Respiratory Sarcopenia as a Novel and Powerful Predictor of Mortality in Older Patients Hospitalized for Heart Failure: Findings from the SONIC-HF Study | Taisuke Nakade (Juntendo Univ., Japan) | ||
| 10:58-11:07 | Development of Multimodal Digital Stethoscope System for Self-monitoring of Heart Failure Status | Qun Wei (Keimyung Univ., Korea) | ||
| 11:07-11:16 | Transcriptomic and Network-based Profiling Reveals Key Molecular Pathways and Therapeutic Targets in Dilated Cardiomyopathy | Nadyatul Husna (Reksodiwiryo Military Hospital, Padang, Indonesia) | ||
| 11:16-11:25 | Imagenetics in Non-ischemic Dilated Cardiomyopathy : Linking Cardiac Magnetic Resonance Imaging Phenotypes to Genotypic Signatures | Jooyeon Lee (Yonsei Univ., Korea) | ||
| 11:25-11:34 | Eligibility for FINEARTS-HF in a Real-world Nationwide Cohort with Heart Failure with Mildly Reduced or Preserved Ejection Fraction | Benedikt Beer (Karolinska Institutet, Sweden) | ||
| 11:34-11:43 | Impact of a Discharge Checklist on Guideline-directed Medical Therapy Adherence and Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: A Comparative Observational Study | Eunjoung Choi (Korea Univ., Korea) | ||
| 11:43-11:52 | Modeling HeartBrain Crosstalk in Heart Failure under SGLT2 Inhibition: A Digital Twin Simulation Using Transcriptomics and LigandReceptor Networks | Javad Alizargar (National Taipei Univ., Taiwan) | ||
| 11:52-12:01 | Distinct Inflammasome and Type I Interferon Pathways Drive Divergent Immune Dynamics in Vaccine-associated and Conventional Myocarditis | Yongjae Lee (KAIST, Korea) | ||
Luncheon Session 6 
| Room C | ||||
| 12:05-13:00 |
KOR
Luncheon Session 6
|
Il Suk Sohn (Kyung Hee Univ., Korea)
, Hae-Young Lee (Seoul National Univ., Korea) |
||
| 12:05-12:30 | CV Benefits of Dapagliflozin in Heart Failure | Ju-Hee Lee (Chungbuk National Univ., Korea) | ||
| 12:30-13:00 | Hypertension Management with Valsartan & Amlodipine | Min-Seok Kim (Ulsan Univ., Korea) | ||
[Joint Session with NIH] Collaborative Research for Advancing Heart Failure Science
|
Room C Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | KOR [Joint Session with NIH] Collaborative Research for Advancing Heart Failure Science |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Won-Ho Kim (Korea National Institute of Health, Korea) |
||
| 심부전 연구자들이 국가적 연구 자원과 데이터베이스를 이해하고, 인공지능·디지털 헬스·유전체 분석 등 최신 융합기술을 활용한 공동 연구 전략을 수립할 수 있도록 한다. | ||||
| 심부전 연구를 위한 많은 연구 자원과 데이터베이스가 있다는 것은 알고 있지만 구체적으로 어떤 것들이 있고 어떻게 활용할 수 있는지 모르는 경우가 많다. 따라서 막연하게만 알고 있는 연구 자원에 대해서 알아보고 이것을 어떻게 얻고 분석할 수 있을지에 대하여 기초부터 차근차근 알아보는 시간이다. | ||||
| 13:00-13:10 | 어렵지 않아요: 자원 신청부터 활용까지 |
|
Hyun Joung Lim (Korea National Institute of Health, Korea) | |
| 13:10-13:20 | 당신의 연구에 필요한 유전체 · 오믹스 데이터, 우리가 지원합니다 |
|
Sang Cheol Kim (Korea National Institute of Health, Korea) | |
| 13:20-13:30 | 너도 할 수 있어: 국가 자원을 활용한 실제 연구 사례 |
|
Yongho Jee (Ewha Womans Univ., Korea) | |
| 13:30-13:40 | AI와 국가 데이터의 만남: 실전 분석 사례와 가능성 |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 13:40-13:50 | Registry 통합과 미래 활용 전략, Pragmatic RCT로 나아가는 길 |
|
Jong-Chan Youn (The Catholic Univ., Korea) | |
| 13:50-14:20 | Discussion |
Bong-Jo Kim (Korea National Institute of Health, Korea) , Hyo Suk Ahn (The Catholic Univ., Korea) , Ju-Hee Lee (Chungbuk National Univ., Korea) , Jae-Pil Jeon (Korea National Institute of Health, Korea) , Junho Hyun (Ulsan Univ., Korea) |
||
Achieving Survival Benefit in Heart Failure with Beta-Blockers
| Room C | ||||
| 14:20-15:30 |
KOR
Achieving Survival Benefit in Heart Failure with Beta-Blockers |
Shung Chull Chae (Kyungpook National Univ., Korea)
, Jin-Yong Hwang (Gyeongsang National Univ., Korea) |
||
| 14:20-14:50 | The Greatest Advantage of Carvedilol and Its Clinical Utility |
|
Jung Hyun Choi (Pusan National Univ., Korea) | |
| 14:50-15:05 | Sharing Real-World Experience I |
|
Hyemoon Chung (Kyung Hee Univ., Korea) | |
| 15:05-15:20 | Sharing Real-World Experience II |
|
Soo Yong Lee (Pusan National Univ., Korea) | |
| 15:20-15:30 | Discussion | Jihun Jang (Inha Univ., Korea) | ||
[Advanced Heart Failure Research Working Group] Advancing Heart Transplantation: Can We Do Better?
|
Room C Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | KOR [Advanced Heart Failure Research Working Group] Advancing Heart Transplantation: Can We Do Better? |
Seok Min Kang (Yonsei Univ., Korea)
, Jin-Oh Choi (Sungkyunkwan Univ., Korea) |
||
| 심장이식 환자에서 급·아급성 거부반응, 신장기능 악화, 혈관병증(CAV) 등 주요 이식 후 합병증의 조기 진단과 예방 전략을 이해하고, 실제 임상에 적용할 수 있도록 한다. | ||||
| 심장이식 후 생존율 향상과 삶의 질 개선을 위해, 주요 합병증을 예방하기 위한 최신 진단 기법과 예방 전략을 고찰해보고자 한다. | ||||
| 15:40-15:55 | How to Prevent Acute/Subacute Rejection |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:55-16:10 | How to Prevent Biopsy Negative Graft Dysfunction |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 16:10-16:25 | How to Prevent Worsening Renal Function |
|
Jae Yeong Cho (Chonnam National Univ., Korea) | |
| 16:25-16:40 | How to Prevent Coronary Allograft Vasculopathy |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 16:40-17:00 | Discussion |
Jaewon Oh (Yonsei Univ., Korea) , Jong-Chan Youn (The Catholic Univ., Korea) , Hyun-Jai Cho (Seoul National Univ., Korea) , Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
Moderated Poster 2
| Agora | ||||
| 09:00-10:10 | ENG Moderated Poster 2 | Sukkeun Hong (Bucheon Sejong Hospital, Korea) | ||
| 09:00-09:07 | Use of ARNI and Risk of Atrial Fibrillation and Ischemic Stroke in Patients with HFrEF: A Nationwide Propensity-matched Cohort Study | Young Jun Park (Yonsei Wonju Univ., Korea) | ||
| 09:07-09:14 | Perceptions and Utilization of Digital Health Technologies among Health Professionals in Korea | Sejun Jeon (ROK Army, Korea) | ||
| 09:14-09:21 | Therapeutic Efficacy and Biomarker-driven Insights of Iron Repletion in Heart Failure: A Comprehensive Meta-analysis | Xuemei Zhao (Fuwai Hospital, CAMS & PUMC, China) | ||
| 09:21-09:28 | Integrative Transcriptomic Approach Identifies Key Pathways and Drug Candidates for Heart Failure | Nadyatul Husna (Reksodiwiryo Military Hospital, Padang, Indonesia) | ||
| 09:28-09:35 | Prognostic Value of QRS Duration in Acute Myocarditis: Insights from a Multicenter Cohort Study | Jihee Son (Sungkyunkwan Univ., Korea) | ||
| 09:35-09:42 | Predicting Prognosis in Heart Failure Using Left Atrial Volume Index: A Marker beyond the Ejection Fraction | Farrukh Malik (National Institute of Cardiovascular Diseases, Pakistan) | ||
| 09:42-09:49 | The Intertwining of Rotating Night Shifts and the Practice of Consuming Light Meals Late at Night Can Heighten the Likelihood of Developing Hypertension, Obesity and Cardiovascular Diseases | Qulsoom Naz (King George's Medical Univ., India) | ||
| 09:49-09:56 | Disease Modeling of FLNC-related Dilated Cardiomyopathy Using hiPSC-derived Cardiac Fibroblasts | Suyeon Jin (Yonsei Univ., Korea) | ||
| 09:56-10:03 | Prognostic Value of Changes in NT-proBNP and sST2 Level in Patients with Chronic Heart Failure and Reduced Ejection Fraction after Undergoing Acute Decompensation during Five Years of Follow-up | Marina Muksinova (National Medical Research Center of Cardiology, Russia) | ||
| 10:03-10:10 | Cardiac Magnetic Resonance Imaging-guided Prediction of Pathogenic Variants in Non-ischemic Dilated Cardiomyopathy | Jooyeon Lee (Yonsei Univ., Korea) | ||
HOPE “Interactive Mentor-Mentee Matching Session”
|
Agora Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | KOR HOPE “Interactive Mentor-Mentee Matching Session” |
Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
, Hyung Yoon Kim (Incheon Sejong Hospital, Korea) |
||
| Moderator: Min Sun Kim (Pusan National Univ., Korea) | ||||
| 심부전 분야의 연구 관심사 및 사회적·개인적 경험을 바탕으로 멘토-멘티 간 실질적인 학술적, 인적 교류를 도모한다. 참가자들이 세션 후에도 지속 가능한 관계를 유지하며, 향후 공동 연구나 진로 멘토링으로 이어질 수 있는 기반을 마련한다. | ||||
| 본 세션은 대한심부전학회 회원 간의 학술적 연계뿐 아니라 진로 및 인생 경험을 공유하는 멘토링 기회를 확대하기 위해 기획되었다. 연구 주제 기반의 실시간 멘토-멘티 매칭과 자유로운 소셜 매칭 두 가지 파트로 구성되며, 이를 통해 참가자는 단발성 만남이 아닌 후속 1:1 멘토링 또는 공동 연구 논의로 발전할 수 있는 실질적 출발점을 갖게 된다. | ||||
| 10:40-10:47 | 심장성 쇼크 다기관 연구의 경험 나누기 |
|
Jeong Hoon Yang (Sungkyunkwan Univ., Korea) | |
| 10:47-10:54 | 임상에 기반을 둔 기초 및 유전체 연구, 어떻게 시작할까? |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 10:54-11:00 | 심부전의 강점을 살려 필드를 넘나드는 연구의 기획과 진행 |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 11:00-11:30 | Mentee Match-Up / Round Table Meeting | |||
| 11:30-11:37 | 학회 경험과 네트워킹 팁 |
|
Wook-Jin Chung (Gachon Univ., Korea) | |
| 11:37-11:44 | 해외연수 준비 및 적응 |
|
Jin Joo Park (Seoul National Univ., Korea) | |
| 11:44-11:51 | 일과 가정의 균형 유지 |
|
Jin-Ok Jeong (Chungnam National Univ., Korea) | |
| 11:51-12:00 | Q&A | |||
EuroVision in Heart Failure: Live Talk with the Authors!
|
Agora Learning Objective + Session Rationale + |
||||
| 13:00-14:15 | ENG EuroVision in Heart Failure: Live Talk with the Authors! |
Jin-Ok Jeong (Chungnam National Univ., Korea)
, Marco Metra (University of Brescia, Italy) HOPE Facilitator Yoonjee Park (Bucheon Sejong Hospital, Korea) |
||
| Gain insights into the process of planning and executing multicenter registries, and hear the invited speaker share their experiences in clinical practice, research, and their personal life. | ||||
| Join informal and engaging discussions with key representatives of the HFA of the ESC, while gaining valuable insights from experienced senior physicians who have spearheaded pioneering efforts across diverse clinical settings. | ||||
| 13:00-13:10 | Short Introduction and Warm up | |||
| 13:10-13:25 | SWED-HF: How Sweden Assembled a Global Model |
|
Gianluigi Savarese (Karolinska Institutet, Sweden) | |
| 13:25-13:40 | From Idea to Impact: How a Diuretic Trial Made It to NEJM |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 13:40-14:10 | Floor Talk |
Jiwon Seo (Yonsei Univ., Korea) , Sunki Lee (Korea Univ., Korea) |
||
| 14:10-14:15 | Wrap up Talk | |||
Moderated Poster 3
| Agora | ||||
| 14:20-15:02 | ENG Moderated Poster 3 | Sung Kee Ryu (Ewha Womans Univ., Korea) | ||
| 14:20-14:27 | The Role of Multi-parametric Echocardiographic Evaluation at the Outpatient Clinic on Adverse Events in Adult Heart Transplant Patients | Jiwon Park (Keimyung Univ., Korea) | ||
| 14:27-14:34 | Effect of Ivabradine on Heart Failure Patients According to Baseline Serum Natriuretic Peptide Level | Taeil Yang (Gachon Univ., Korea) | ||
| 14:34-14:41 | Implementation and Evaluation of a Social Networking Service-based Mobile Patient-generated Health Data System with Direct Electronic Medical Record Integration: A Prospective Observational Study | Eunjoung Choi (Korea Univ., Korea) | ||
| 14:41-14:48 | Differences in Ischemic Versus Non-ischemic Heart Failure on Guideline Adherence and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from the TRANS-HF Trial | Yinsoo Lee (The Catholic Univ., Korea) | ||
| 14:48-14:55 | An Echocardiography-based Machine Learning Model for Predicting Onset of Heart Failure | Jin Joo Park (Seoul National Univ., Korea) | ||
| 14:55-15:02 | Cancer Risks in Heart Failure Patients: Insights from Ischemic and Non-ischemic Cardiomyopathy | Eun-Young Kim (The Catholic Univ., Korea) | ||
- The Korean Society of Heart Failure
- TEL: +82-2-3275-5335 | FAX: +82-2-3275-5336 | E-Mail: kshf3@kshf.or.kr
- Business Registration No. : 234-82- 63394 | Name of Representative : ByungSu Yoo
